Jim Cramer Won’t Buy Micron Tech or Monsanto, Likes Big Name Biotechs

Micron Technology and Monsanto report earnings next week but Jim Cramer says he doesn't love either and would sell into any strength. Cramer says in the Micron conference call investors should expect to hear that the business doesn’t look as strong going forward. He says Dow Chemical is a better way to play the agriculture business than Monsanto. He says as the quarter ends investors should focus on the rebound in high quality techs and should return to big biotech names which he think have bottomed, including Celgene, Gilead, Biogen, Regeneron, He remains concerned about the more speculative biotechs.